PATENT CLAIM ANALYSIS

Application Number: 16050472
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-02
Patent Classification: ["514", "002300"]

Abstract:
The present disclosure relates to novel cleavable conjugates of antibiotics and an antibacterial cell-penetrating peptide, and methods to make and use the novel cleavable conjugates of antibiotics and an antibacterial cell-penetrating peptide.

Claim (Index 10):
The compound of  claim 2  wherein, R 1  or R 1 \u2014X represents an aminoglycoside antibiotics moiety, and the aminoglycoside antibiotics is selected from the group consisting of Gentamicin, Kanamycin, Tobramycin, Amikacin, Neomycin, Plazomicin, and any derivative thereof; R 2  and R 3  are isobutyl group; R 4  is hydrogen; L 1  is \u2014(CH 2 ) 3 \u2014, L 2  is \u2014(CH 2 ) 3 \u2014, and L 3  is \u2014(CH 2 )\u2014; X is O; and n is 4.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 95.0
- Lexical Diversity: 1.61905
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13122156', '14713857', '15107531', '11662806', '14117742']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7898189689156776
- 35 USC 102 Novelty (BERT): 0.4854566377294356
- Combined Prediction Score: 0.7593827357970534
- Mean Citation Score: 195.92352
- Max Citation Score: 203.26004
- Similarity Product: 147.5369029660034

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test